DFS and OS by treatment arm for the favorable cytogenetic risk group. (A) Predicted 5-year DFS was 57% for the HiDAC group (n = 108; red line) and 39% for the multiagent CT group (n = 110; blue line; P = .050). (B) Predicted 5-year OS was 75% for the HiDAC group (n = 108; red line) and 66% for the multiagent CT group (n = 110; blue line; P = .174).